Header cover image

Swiss (SMI) Biotech Industry Analysis

UpdatedJun 26, 2026
DataAggregated Company Financials
Companies4
  • 7D0.3%
  • 3M-9.7%
  • 1Y-18.2%
  • YTD-27.0%

Over the last 7 days, the Biotech industry has dropped 2.2%, driven by a pullback from Kuros Biosciences of 6.6%. In contrast, Idorsia has gained 26%. Overall the industry is down 13% in 12 months. Looking forward, earnings are forecast to grow by 36% annually.

Industry Valuation and Performance

Has the Swiss Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Jun 2026CHF 1.5bCHF 351.3m-CHF 25,696,395.50190.1x-59.4x4.3x
Sun, 24 May 2026CHF 1.7bCHF 347.0m-CHF 15,851,773.16228.8x-107.2x4.9x
Tue, 21 Apr 2026CHF 1.8bCHF 346.1m-CHF 19,494,554.58253.1x-93x5.2x
Thu, 19 Mar 2026CHF 1.8bCHF 348.2m-CHF 19,459,003.30253x-92x5.1x
Sat, 14 Feb 2026CHF 2.0bCHF 339.6mCHF 6.5m9.6x303.4x5.8x
Mon, 12 Jan 2026CHF 2.1bCHF 339.6mCHF 6.5m9.8x324.4x6.2x
Wed, 10 Dec 2025CHF 2.0bCHF 343.6m-CHF 10,514,000.008.7x-186.9x5.7x
Fri, 07 Nov 2025CHF 1.8bCHF 343.6m-CHF 10,514,000.007.6x-172.3x5.3x
Sun, 05 Oct 2025CHF 1.9bCHF 344.3m-CHF 15,083,000.008.2x-123.2x5.4x
Tue, 02 Sep 2025CHF 1.9bCHF 383.4m-CHF 57,057,000.007.9x-32.5x4.8x
Thu, 31 Jul 2025CHF 2.2bCHF 333.9m-CHF 44,705,000.009.1x-48.8x6.5x
Sat, 28 Jun 2025CHF 2.0bCHF 333.9m-CHF 44,705,000.007.5x-43.7x5.9x
Mon, 26 May 2025CHF 1.8bCHF 333.9m-CHF 44,705,000.007x-40.2x5.4x
Wed, 23 Apr 2025CHF 1.6bCHF 411.1mCHF 65.6m4.6x24.9x4x
Fri, 21 Mar 2025CHF 1.7bCHF 409.3m-CHF 35,110,868.005.2x-47.6x4.1x
Sun, 16 Feb 2025CHF 2.0bCHF 327.8m-CHF 127,073,868.003.3x-15.4x6x
Tue, 14 Jan 2025CHF 1.8bCHF 330.3m-CHF 75,131,868.002.5x-23.4x5.3x
Thu, 12 Dec 2024CHF 1.7bCHF 330.9m-CHF 87,805,465.001.9x-19x5x
Sat, 09 Nov 2024CHF 1.9bCHF 331.2m-CHF 86,988,629.001.7x-22.4x5.9x
Mon, 07 Oct 2024CHF 1.5bCHF 333.1m-CHF 82,023,629.001.7x-18.7x4.6x
Wed, 04 Sep 2024CHF 1.5bCHF 323.4m-CHF 89,161,264.002x-16.8x4.6x
Fri, 02 Aug 2024CHF 799.5mCHF 151.7m-CHF 146,197,264.001.6x-5.5x5.3x
Sun, 30 Jun 2024CHF 755.7mCHF 151.7m-CHF 146,197,264.001.4x-5.2x5x
Tue, 28 May 2024CHF 545.0mCHF 170.5m-CHF 131,456,924.261x-4.1x3.2x
Thu, 25 Apr 2024CHF 392.0mCHF 67.2m-CHF 172,299,290.500.07x-2.3x5.8x
Sat, 23 Mar 2024CHF 340.9mCHF 67.3m-CHF 173,226,506.340.2x-2x5.1x
Mon, 19 Feb 2024CHF 398.9mCHF 55.5m-CHF 173,229,467.361x-2.3x7.2x
Wed, 17 Jan 2024CHF 342.3mCHF 317.6m-CHF 176,008,605.000.5x-1.9x1.1x
Fri, 15 Dec 2023CHF 296.7mCHF 317.6m-CHF 208,646,316.00n/a-1.4x0.9x
Sun, 12 Nov 2023CHF 292.3mCHF 318.5m-CHF 211,286,620.00n/a-1.4x0.9x
Tue, 10 Oct 2023CHF 249.3mCHF 318.4m-CHF 213,277,782.00n/a-1.2x0.8x
Thu, 07 Sep 2023CHF 318.1mCHF 318.6m-CHF 188,937,509.00n/a-1.7x1x
Sat, 05 Aug 2023CHF 528.8mCHF 323.7m-CHF 180,004,478.00n/a-2.9x1.6x
Mon, 03 Jul 2023CHF 302.2mCHF 330.6m-CHF 180,777,833.00n/a-1.7x0.9x
Price to Earnings Ratio

-1.7x


Total Market Cap: CHF 302.2mTotal Earnings: -CHF 180,777,833.00Total Revenue: CHF 330.6mTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Biotech Industry Price to Earnings3Y Average -14.1x202420252026
Current Industry PE
  • Investors are relatively neutral on the Swiss Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 4.4x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 2.1% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market2.77%
Healthcare5.71%
Biotech0.35%
Biotech0.35%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
IDIA IdorsiaCHF 6.8620.9%
+CHF 302.2m
239.6%PS8x
BSLN Basilea PharmaceuticaCHF 51.901.2%
+CHF 7.4m
9.0%PE16x
MOLN Molecular PartnersCHF 3.182.9%
+CHF 3.4m
7.4%PB1.7x
MMTX MindMaze Therapeutics HoldingCHF 0.220.5%
+CHF 152.6k
n/aPS51.5x

Latest News